All Stories

  1. Encephalocraniocutaneous lipomatosis—a neuroradiological perspective
  2. ARID2-related disorder: further delineation of the clinical phenotype of 27 novel individuals and description of an epigenetic signature
  3. Epilepsy as a Novel Phenotype of BPTF-Related Disorders
  4. Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies
  5. Inhibition of post-lanosterol biosynthesis by fentanyl: potential implications for Fetal Fentanyl Syndrome (FFS)
  6. Variants in ZFX are associated with an X-linked neurodevelopmental disorder with recurrent facial gestalt
  7. The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy
  8. Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
  9. Genomic analyses in Cornelia de Lange Syndrome and related diagnoses: Novel candidate genes, genotype–phenotype correlations and common mechanisms
  10. GestaltMatcher Database - A global reference for facial phenotypic variability in rare human diseases
  11. A novel syndrome associated with prenatal fentanyl exposure
  12. Expansion of the clinical and molecular spectrum of WWOX‐related epileptic encephalopathy
  13. Central nervous system involvement in individuals withRASopathies
  14. Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants
  15. Cutaneous vascular anomalies associated with a mosaic variant of AKT3: Genetic analysis continues to refine the diagnosis, nomenclature, and classification of vascular anomalies
  16. The seventh international RASopathies symposium: Pathways to a cure—expanding knowledge, enhancing research, and therapeutic discovery
  17. GestaltMatcher facilitates rare disease matching using facial phenotype descriptors
  18. Craniosynostosis is a feature of Costello syndrome
  19. Molecular Genetic Testing for Kidney Disorders During the COVID-19 Pandemic
  20. The Genetic Testing Stewardship Program:
  21. Response to Hamosh et al.
  22. De novo DHDDS variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus
  23. Key Considerations for Selecting a Genomic Decision Support Platform for Implementing Pharmacogenomics
  24. Disruption of RFX family transcription factors causes autism, attention-deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior
  25. Nucleocytoplasmic transport of the RNA-binding protein CELF2 regulates neural stem cell fates
  26. Implementation and evaluation of a curriculum on the assessment and treatment of disruptive behaviour disorders
  27. Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann‐Steiner syndrome
  28. TAOK1 is associated with neurodevelopmental disorder and essential for neuronal maturation and cortical development
  29. Syndromic disorders caused by gain-of-function variants in KCNH1, KCNK4, and KCNN3—a subgroup of K+ channelopathies
  30. Phenotypic expansion of the BPTF‐related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies
  31. Novel genetic testing model: A collaboration between genetic counselors and nephrology
  32. 41st Annual David W. Smith workshop on malformations and morphogenesis: Abstracts of the 2020 annual meeting
  33. GestaltMatcher: Overcoming the limits of rare disease matching using facial phenotypic descriptors
  34. A dyadic approach to the delineation of diagnostic entities in clinical genomics
  35. Nucleocytoplasmic Transport of RNA-Binding Proteins Regulates Neural Stem Cell Fates 
  36. Inherited intragenic PBX1 deletion: Expanding the phenotype
  37. Disruption of RFX family transcription factors causes autism, attention deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior
  38. Early infantile epileptic encephalopathy due to biallelic pathogenic variants in PIGQ : Report of seven new subjects and review of the literature
  39. Mutations in FAM50A suggest that Armfield XLID syndrome is a spliceosomopathy
  40. The novel duplication HRAS c.186_206dup p.(Glu62_Arg68dup): clinical and functional aspects
  41. GATAD2B-associatedneurodevelopmental disorder (GAND): clinical and molecular insights into a NuRD-relateddisorder
  42. Correction: GATAD2B-associated neurodevelopmental disorder (GAND): clinical and molecular insights into a NuRD-related disorder
  43. De novo and inherited variants in ZNF292 underlie a neurodevelopmental disorder with features of autism spectrum disorder
  44. De novo heterozygous missense and loss‐of‐function variants in CDC42BPB are associated with a neurodevelopmental phenotype
  45. Advancing RAS/RASopathy therapies: An NCI‐sponsored intramural and extramural collaboration for the study of RASopathies
  46. MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis
  47. The sixth international RASopathies symposium: Precision medicine—From promise to practice
  48. PEDIA: prioritization of exome data by image analysis
  49. Medically actionable comorbidities in adults with Costello syndrome
  50. Clinical spectrum of individuals with pathogenic N F1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype–phenotype study in neurofibromatosis type 1
  51. Using facial analysis technology in a typical genetic clinic: experience from 30 individuals from a single institution
  52. Costello syndrome: Clinical phenotype, genotype, and management guidelines
  53. Reanalysis of Clinical Exome Sequencing Data
  54. Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome
  55. Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome
  56. Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP
  57. Biallelic sequence variants in INTS1 in patients with developmental delays, cataracts, and craniofacial anomalies
  58. GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome
  59. Identifying facial phenotypes of genetic disorders using deep learning
  60. PEDIA: Prioritization of Exome Data by Image Analysis
  61. ClinGen’s RASopathy Expert Panel consensus methods for variant interpretation
  62. Assessing the gene–disease association of 19 genes with the RASopathies using the ClinGen gene curation framework
  63. Proceedings of the fifth international RASopathies symposium: When development and cancer intersect
  64. Imaging phenotype of multiple mitochondrial dysfunction syndrome 2, a rare BOLA3‐associated leukodystrophy
  65. Urine cell-free DNA is a biomarker for nephroblastomatosis or Wilms tumor in PIK3CA-related overgrowth spectrum (PROS)
  66. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients
  67. Further delineation of Aymé‐Gripp syndrome and use of automated facial analysis tool
  68. Assessing the Gene-Disease Association of 19 Genes with the RASopathies using the ClinGen Gene Curation Framework
  69. Pathogenic variants in E3 ubiquitin ligase RLIM/RNF12 lead to a syndromic X-linked intellectual disability and behavior disorder
  70. Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis
  71. Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848
  72. Expanding the neurodevelopmental phenotype of PURA syndrome
  73. Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance
  74. Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly
  75. X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD) associated with mutations in AIFM1
  76. Phenotypic and molecular characterisation of CDK13-related congenital heart defects, dysmorphic facial features and intellectual developmental disorders
  77. Computational Prediction of Position Effects of Apparently Balanced Human Chromosomal Rearrangements
  78. Constitutional LZTR1 mutation presenting with a unilateral vestibular schwannoma in a teenager
  79. Age‐related differences in prevalence of autism spectrum disorder symptoms in children and adolescents with Costello syndrome
  80. Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome Patient
  81. Phenotypic spectrum of Costello syndrome individuals harboring the rare HRAS mutation p.Gly13Asp
  82. Attenuated phenotype of Costello syndrome and early death in a patient with an HRAS mutation (c.179G>T; p.Gly60Val) affecting signalling dynamics
  83. A novel patient with an attenuated Costello syndrome phenotype due to an HRAS mutation affecting codon 146—Literature review and update
  84. Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy
  85. Microcephaly, intractable seizures and developmental delay caused by biallelic variants in TBCD: further delineation of a new chaperone‐mediated tubulinopathy
  86. The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies
  87. Paternal uniparental disomy with segmental loss of heterozygosity of chromosome 11 are hallmark characteristics of syndromic and sporadic embryonal rhabdomyosarcoma
  88. PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution
  89. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair
  90. Nephroblastomatosis or Wilms tumor in a fourth patient with a somaticPIK3CAmutation
  91. The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway
  92. 36th Annual David W. Smith Workshop on Malformations and Morphogenesis: Abstracts of the 2015 annual meeting
  93. The role of objective facial analysis using FDNA in making diagnoses following whole exome analysis. Report of two patients with mutations in the BAF complex genes
  94. Maternal uniparental disomy of chromosome 20: a novel imprinting disorder of growth failure
  95. Mandibulofacial Dysostosis with Microcephaly: Mutation and Database Update
  96. Paternal uniparental disomy 11p15.5 in the pancreatic nodule of an infant with Costello syndrome: Shared mechanism for hyperinsulinemic hypoglycemia in neonates with Costello and Beckwith-Wiedemann syndrome and somatic loss of heterozygosity in Costello s
  97. High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype–Phenotype Correlation
  98. Differentiating between copy‐number‐variation and gain‐of‐function mutation
  99. Mutations inRIT1cause Noonan syndrome - additional functional evidence and expanding the clinical phenotype
  100. Mutations Impairing GSK3-Mediated MAF Phosphorylation Cause Cataract, Deafness, Intellectual Disability, Seizures, and a Down Syndrome-like Facies
  101. An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences
  102. The third international meeting on genetic disorders in the RAS/MAPK pathway: Towards a therapeutic approach
  103. PIAS4 is associated with macro/microcephaly in the novel interstitial 19p13.3 microdeletion/microduplication syndrome
  104. Germline gain-of-function mutations in AFF4 cause a developmental syndrome functionally linking the super elongation complex and cohesin
  105. Truncating mutations in the last exon ofNOTCH3cause lateral meningocele syndrome
  106. Early-Lethal Costello Syndrome Due to Rare HRAS Tandem Base Substitution (c.35_36GC>AA; p.G12E)–Associated Pulmonary Vascular Disease
  107. Function and disability in children with Costello syndrome and Cardiofaciocutaneous syndrome
  108. Mutations in LAMA1 Cause Cerebellar Dysplasia and Cysts with and without Retinal Dystrophy
  109. Mutations in LAMA1 Cause Cerebellar Dysplasia and Cysts with and without Retinal Dystrophy
  110. Cutis laxa with pulmonary emphysema, conjunctivochalasis, nasolacrimal duct obstruction, abnormal hair, and a novelFBLN5mutation
  111. Diamond–Blackfan anemia with mandibulofacial dystostosis is heterogeneous, including the novel DBA genes TSR2 and RPS28
  112. Axenfeld‐Rieger syndrome: Further clinical and array delineation of four unrelated patients with a 4q25 microdeletion
  113. Novel SMAD4 mutation causing Myhre syndrome
  114. Screening children with neurofibromatosis type 1 for autism spectrum disorder
  115. De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome
  116. Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism
  117. Neuromotor synapses in Escobar syndrome
  118. Expanding the SHOC2 mutation associated phenotype of noonan syndrome with loose anagen hair: Structural brain anomalies and myelofibrosis
  119. Verbal memory functioning in adolescents and young adults with costello syndrome: Evidence for relative preservation in recognition memory
  120. Assessing genotype–phenotype correlation in Costello syndrome using a severity score
  121. The duplication 17p13.3 phenotype: Analysis of 21 families delineates developmental, behavioral and brain abnormalities, and rare variant phenotypes
  122. Orthopedic manifestations and implications for individuals with Costello syndrome
  123. Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies
  124. Exome Analysis in Clinical Practice: Expanding the Phenotype of Bartsocas–Papas Syndrome
  125. Keratoconus in Costello Syndrome
  126. De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome
  127. Exonic Deletions in AUTS2 Cause a Syndromic Form of Intellectual Disability and Suggest a Critical Role for the C Terminus
  128. Cardiac anomalies in Axenfeld–Rieger syndrome due to a novel FOXC1 mutation
  129. Special section. Syndrome‐specific growth charts
  130. Beyond Gómez‐López‐Hernández syndrome: Recurring phenotypic themes in rhombencephalosynapsis
  131. Normative growth charts for individuals with Costello syndrome
  132. A novel HRAS substitution (c.266C>G; p.S89C) resulting in decreased downstream signaling suggests a new dimension of RAS pathway dysregulation in human development
  133. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
  134. Transmission of the rare HRAS mutation (c. 173C > T; p.T58I) further illustrates its attenuated phenotype
  135. Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations
  136. De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome
  137. Megalencephaly‐capillary malformation (MCAP) and megalencephaly‐polydactyly‐polymicrogyria‐hydrocephalus (MPPH) syndromes: Two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis
  138. Long‐term survival in TARP syndrome and confirmation of RBM10 as the disease‐causing gene
  139. Costello syndrome: A Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations
  140. Molecular confirmation of HRAS p.G12S in siblings with Costello syndrome
  141. Lateral meningocele syndrome and Hajdu–Cheney syndrome: Different disorders with overlapping phenotypes
  142. Distinctive phenotype in 9 patients with deletion of chromosome 1q24‐q25
  143. Cardio‐facio‐cutaneous syndrome: Does genotype predict phenotype?
  144. Neurocognitive, adaptive, and behavioral functioning of individuals with Costello syndrome: A review
  145. Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C
  146. Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: A Ras/MAPK pathway syndrome
  147. Grade 1 microtia, wide anterior fontanel and novel type tracheo‐esophageal fistula in methimazole embryopathy
  148. CNS imaging is a key diagnostic tool in the evaluation of patients with CFC syndrome: Two cases and literature review
  149. Clinical Approach to Craniosynostosis
  150. X‐linked hereditary hemihypotrophy hemiparesis hemiathetosis
  151. Agenesis of the corpus callosum and congenital lymphedema: A novel recognizable syndrome?
  152. High incidence of progressive postnatal cerebellar enlargement in Costello syndrome: Brain overgrowth associated with HRAS mutations as the likely cause of structural brain and spinal cord abnormalities
  153. Costello Syndrome
  154. Craniosynostosis Syndromes
  155. Living with Costello syndrome: Quality of life issues in older individuals
  156. Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back
  157. Longitudinal course of cognitive, adaptive, and behavioral characteristics in Costello syndrome
  158. Significant overlap and possible identity of macrocephaly capillary malformation and megalencephaly polymicrogyria‐polydactyly hydrocephalus syndromes
  159. Prenatal features of Costello syndrome: ultrasonographic findings and atrial tachycardia
  160. Male‐to‐male transmission of Costello syndrome: G12S HRAS germline mutation inherited from a father with somatic mosaicism
  161. Preaxial hallucal polydactyly as a marker for diabetic embryopathy
  162. Molecular aspects, clinical aspects and possible treatment modalities for Costello syndrome: Proceedings from the 1st International Costello Syndrome Research Symposium 2007
  163. The diagnosis of Costello syndrome: Nomenclature in Ras/MAPK pathway disorders
  164. Clarification of previously reported Costello syndrome patients
  165. Costello syndrome associated with novel germline HRAS mutations: An attenuated phenotype?
  166. Expanding the phenotype of SPONASTRIME dysplasia to include short dental roots, hypogammaglobulinemia, and cataracts
  167. Neuromuscular and Chest Wall Disorders
  168. The Molecular Basis of Costello Syndrome
  169. Costello syndrome and related disorders
  170. Longitudinal assessment of cognitive characteristics in Costello syndrome
  171. Hepatoblastoma and heart transplantation in a patient with cardio‐facio‐cutaneous syndrome
  172. Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio‐facio‐cutaneous syndrome from Costello syndrome
  173. Judith Hall, Judith Allanson, Karen Gripp, Anne Slavotinek (eds): Handbook of Physical Measurement, 2007
  174. Somatic mosaicism for an HRAS mutation causes Costello syndrome
  175. Paternal bias in parental origin ofHRASmutations in Costello syndrome
  176. HRAS mutation analysis in Costello syndrome: Genotype and phenotype correlation
  177. Wilms tumor in an 11‐year‐old with hemihyperplasia
  178. Adult phenotype in Costello syndrome (Am J Med Genet 136A: 128–135, 2005)
  179. Tumor predisposition in Costello syndrome
  180. The adult phenotype in Costello syndrome
  181. Observation of a parental inversion variant in a rare Williams–Beuren syndrome family with two affected children
  182. C raniosynostosis Syndromes
  183. C ostello Syndrome
  184. Myocardial storage of chondroitin sulfate-containing moieties in Costello syndrome patients with severe hypertrophic cardiomyopathy
  185. Craniosynostosis: Another feature of the 22q11.2 deletion syndrome
  186. Further delineation of Kabuki syndrome in 48 well‐defined new individuals
  187. Megalencephaly and Perisylvian Polymicrogyria with Postaxial Polydactyly and Hydrocephalus: A Rare Brain Malformation Syndrome Associated with Mental Retardation and Seizures
  188. Molecular Analysis of Patients with Synostotic Frontal Plagiocephaly (Unilateral Coronal Synostosis)
  189. Genetics of Colorectal Cancer
  190. Human Chromosome 7: DNA Sequence and Biology
  191. Further delineation of cardiac abnormalities in Costello syndrome
  192. Five additional Costello syndrome patients with rhabdomyosarcoma: Proposal for a tumor screening protocol
  193. Bilateral microtia and cleft palate in cousins with Diamond-Blackfan anemia
  194. Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination
  195. Craniosynostosis: Molecular testing?a necessity for counseling
  196. Mutations in the humanTWIST gene
  197. Decreased Elastin Deposition and High Proliferation of Fibroblasts from Costello Syndrome Are Related to Functional Deficiency in the 67-kD Elastin-Binding Protein
  198. Mutations in the humanTWIST gene
  199. Not Antley-Bixler syndrome
  200. Not Antley‐Bixler syndrome
  201. Aphallia as part of urorectal septum malformation sequence in an infant of a diabetic mother
  202. Identification of a genetic cause for isolated unilateral coronal synostosis: A unique mutation in the fibroblast growth factor receptor 3
  203. Reply to Aymé and Philip
  204. Reply to Aymé and Philip
  205. Chiari malformation and tonsillar ectopia in twin brothers and father with autosomal dominant spondylo-epiphyseal dysplasia tarda
  206. Extending the spectrum of distal arthrogryposis
  207. Apparently new syndrome of congenital cataracts, sensorineural deafness, Down syndrome-like facial appearance, short stature, and mental retardation
  208. Chromosomal mapping of the genes GPRK5 and GPRK6 encoding G protein-coupled receptor kinases GRK5 and GRK6